Biolase inc.
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It ...
Medical Pharmaceuticals /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of...Validates BIOLASE REPAIR ® Perio Protocol is a Superior Alternative as it pertains to patient reported outcomes.. LAKE FOREST, Calif., Nov. 8, 2023 /PRNewswire/ -- BIOLASE, Inc.(NASDAQ: BIOL ...12 nov 2020 ... This is "Advancing Dentistry: Benefits of the Diode Laser in Your Everyday Hygiene Appointments" by BIOLASE, Inc. on Vimeo, the home for ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…
BIOLASE, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is …
BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Thursday, November, 9th. The medical technology company reported ($3.89) EPS for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software.FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of 14,000,000 shares of its common stock at a price to the public of $1.03 per share, less underwriting discounts and commissions. The …Nov 8, 2023 · Jun 15, 2023 6:30am EDT. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…. LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. , a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000...
700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg)
BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…
FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering of 14,000,000 shares of its common stock at a price to the public of $1.03 per share, less underwriting discounts and commissions.Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC CI Nov. 09: BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CIBIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…The U.S. Food and Drug Administration (FDA) approved Waterlase for the treatment of hard tissue in October 1998, one month before Jeffrey W. Jones was appointed ...
BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable Preferred Stock, par ...Filter stock price historical data by date with the ability to view Opens, Highs, Lows, Closes, VWAPs, Volume % Change, Change, Trade Value and Trades. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to ...BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 720380.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the second quarter ended June 30, 2022, and to answer questions. To access the live call, dial 1-877-545-0320 (U.S.) or +1 973-528-0002 (International) and provide the following code: 838343.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ...
LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ...About BIOLASE, Inc. BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of ...
Seven primer pairs ( Table 1) (Macrogen, Korea) were used for detection of β-lactamases genes (bla TEM, bla SHV, bla CTXM-1, bla VEB, bla OXA-1) and class C …150 Royall St. Suite V. Canton MA 02021. Under the rights offering, BIOLASE will distribute one non-transferable subscription right for each share of common stock and each warrant issued in a private placement transaction that was consummated on June 10, 2020 (on an as-if-converted-to-common-stock basis) held on the Record Date (July 1, …LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. , a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000...LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ...Dr. Morrow brings extensive clinical, dental and DSO experience to help expand laser adoption globally. LAKE FOREST, Calif., Oct. 13, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer ("CDO"), effective …BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including …Strategically Located Facility To Provide Best-in-Class Education & Training Programs. LAKE FOREST, Calif., June 15, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced plans to open a state-of-the-art training facility, "BIOLASE Education Center" with an Open House scheduled …
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It ...
Biolase en España, líderes en tecnología dental. Biolase es el líder mundial en el desarrollo y la producción de láseres médicos desde hace más de 25 años!
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all ...12 nov 2020 ... This is "Advancing Dentistry: Benefits of the Diode Laser in Your Everyday Hygiene Appointments" by BIOLASE, Inc. on Vimeo, the home for ...Global Leader in Dental Lasers. BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes.Nov 9, 2023 • 1:30 pm PST. View Event View All Events. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and …FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...Seven primer pairs ( Table 1) (Macrogen, Korea) were used for detection of β-lactamases genes (bla TEM, bla SHV, bla CTXM-1, bla VEB, bla OXA-1) and class C …Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.Biolase India Private Limited is a Private incorporated on 25 May 2011. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. Its authorized …7 may 2021 ... This is "Advancing Dentistry: Laser-Assisted Management of Endodontic Biofilm" by BIOLASE, Inc. on Vimeo, the home for high quality videos ...The new handpiece uses advanced, proprietary technology to deliver faster healing and quicker recovery for skin-resurfacing patients LAKE FOREST, Calif., Feb. 23, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors …LAKE FOREST, Calif., June 30, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior secured term loan with SWK Funding LLC. The amendment extends the interest-only period of the loan by two quarters to November …
Nov 9, 2023 • 1:30 pm PST. View Event View All Events. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and …Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Instagram:https://instagram. fisher investment fees reviewcola for 2024e mini sandp 500 futures tickercrypto portfolio tracker Feb 27, 2023 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… LAKE FOREST, Calif., Sept. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable Preferred Stock, par value $0.001 per share, with a ... jepq yieldbest stocks for dollar10 Filter stock price historical data by date with the ability to view Opens, Highs, Lows, Closes, VWAPs, Volume % Change, Change, Trade Value and Trades. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to ... us forex brokers comparison LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ...Seven primer pairs ( Table 1) (Macrogen, Korea) were used for detection of β-lactamases genes (bla TEM, bla SHV, bla CTXM-1, bla VEB, bla OXA-1) and class C …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…